Health Care Financing Policy
Testimony before the Medicare Coverage Advisory Committee concerning authoritative drug compendia and coverage of treatments for rare diseases and conditions 
Yes, No, Maybe, Please Ask Again: The Frustrating Tale of Expensive Orphan Drugs Under Medicare Part D 
A Short Guide to Understanding Medicaid 
A Short Guide to Understanding the Olmstead Decision and Its Impact 

